Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1800 2
1887 1
1924 1
1941 1
1946 3
1947 1
1948 2
1950 1
1951 1
1952 6
1953 3
1954 1
1955 5
1956 5
1957 5
1958 3
1959 6
1960 2
1961 5
1962 5
1963 5
1964 2
1966 9
1967 5
1968 6
1969 13
1970 10
1971 8
1972 5
1973 6
1974 12
1975 15
1976 16
1977 20
1978 27
1979 26
1980 20
1981 24
1982 29
1983 31
1984 29
1985 31
1986 41
1987 38
1988 46
1989 68
1990 84
1991 80
1992 71
1993 80
1994 108
1995 111
1996 117
1997 139
1998 145
1999 139
2000 142
2001 141
2002 158
2003 163
2004 211
2005 210
2006 228
2007 258
2008 281
2009 311
2010 355
2011 409
2012 383
2013 452
2014 480
2015 491
2016 486
2017 529
2018 589
2019 595
2020 675
2021 663
2022 654
2023 585
2024 184

Text availability

Article attribute

Article type

Publication date

Search Results

10,159 results

Results by year

Filters applied: . Clear all
Page 1
Single cell clonotypic and transcriptional evolution of multiple myeloma precursor disease.
Dang M, Wang R, Lee HC, Patel KK, Becnel MR, Han G, Thomas SK, Hao D, Chu Y, Weber DM, Lin P, Lutter-Berka Z, Berrios Nolasco DA, Huang M, Bansal H, Song X, Zhang J, Futreal A, Moreno Rueda LY, Symer DE, Green MR, Rojas Hernandez CM, Kroll M, Afshar-Khargan V, Ndacayisaba LJ, Kuhn P, Neelapu SS, Orlowski RZ, Wang L, Manasanch EE. Dang M, et al. Among authors: thomas sk. Cancer Cell. 2023 Jun 12;41(6):1032-1047.e4. doi: 10.1016/j.ccell.2023.05.007. Cancer Cell. 2023. PMID: 37311413
Death-seq identifies regulators of cell death and senolytic therapies.
Colville A, Liu JY, Rodriguez-Mateo C, Thomas S, Ishak HD, Zhou R, Klein JDD, Morgens DW, Goshayeshi A, Salvi JS, Yao D, Spees K, Dixon SJ, Liu C, Rhee JW, Lai C, Wu JC, Bassik MC, Rando TA. Colville A, et al. Among authors: thomas s. Cell Metab. 2023 Oct 3;35(10):1814-1829.e6. doi: 10.1016/j.cmet.2023.08.008. Epub 2023 Sep 11. Cell Metab. 2023. PMID: 37699398
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study.
Pant S, Schuler M, Iyer G, Witt O, Doi T, Qin S, Tabernero J, Reardon DA, Massard C, Minchom A, Lugowska I, Carranza O, Arnold D, Gutierrez M, Winter H, Stuyckens K, Crow L, Najmi S, Hammond C, Thomas S, Santiago-Walker A, Triantos S, Sweiti H, Loriot Y; RAGNAR Investigators. Pant S, et al. Among authors: thomas s. Lancet Oncol. 2023 Aug;24(8):925-935. doi: 10.1016/S1470-2045(23)00275-9. Lancet Oncol. 2023. PMID: 37541273 Clinical Trial.
Introduction to Bionanocomposites.
Thomas S, John MJ, Mathew AP. Thomas S, et al. Nanoscale Adv. 2024 Jan 15;6(3):745-746. doi: 10.1039/d3na90115g. eCollection 2024 Jan 30. Nanoscale Adv. 2024. PMID: 38298578 Free PMC article.
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study.
Weber JS, Carlino MS, Khattak A, Meniawy T, Ansstas G, Taylor MH, Kim KB, McKean M, Long GV, Sullivan RJ, Faries M, Tran TT, Cowey CL, Pecora A, Shaheen M, Segar J, Medina T, Atkinson V, Gibney GT, Luke JJ, Thomas S, Buchbinder EI, Healy JA, Huang M, Morrissey M, Feldman I, Sehgal V, Robert-Tissot C, Hou P, Zhu L, Brown M, Aanur P, Meehan RS, Zaks T. Weber JS, et al. Among authors: thomas s. Lancet. 2024 Feb 17;403(10427):632-644. doi: 10.1016/S0140-6736(23)02268-7. Epub 2024 Jan 18. Lancet. 2024. PMID: 38246194 Clinical Trial.
Foul Experiences.
Pollak M, Thomas S, Pang J, Owiny J. Pollak M, et al. Among authors: thomas s. Lab Anim (NY). 2023 Nov;52(11):262-263. doi: 10.1038/s41684-023-01272-4. Lab Anim (NY). 2023. PMID: 37891345 No abstract available.
Novel Prognostic Staging System for Patients With De Novo Metastatic Breast Cancer.
Plichta JK, Thomas SM, Hayes DF, Chavez-MacGregor M, Allison K, de Los Santos J, Fowler AM, Giuliano AE, Sharma P, Smith BD, van Eycken E, Edge SB, Hortobagyi GN. Plichta JK, et al. Among authors: thomas sm. J Clin Oncol. 2023 May 10;41(14):2546-2560. doi: 10.1200/JCO.22.02222. Epub 2023 Mar 21. J Clin Oncol. 2023. PMID: 36944149
Bivalent Omicron BA.1-Adapted BNT162b2 Booster in Adults Older than 55 Years.
Winokur P, Gayed J, Fitz-Patrick D, Thomas SJ, Diya O, Lockhart S, Xu X, Zhang Y, Bangad V, Schwartz HI, Denham D, Cardona JF, Usdan L, Ginis J, Mensa FJ, Zou J, Xie X, Shi PY, Lu C, Buitrago S, Scully IL, Cooper D, Koury K, Jansen KU, Türeci Ö, Şahin U, Swanson KA, Gruber WC, Kitchin N; C4591031 Clinical Trial Group. Winokur P, et al. Among authors: thomas sj. N Engl J Med. 2023 Jan 19;388(3):214-227. doi: 10.1056/NEJMoa2213082. N Engl J Med. 2023. PMID: 36652353 Free PMC article. Clinical Trial.
Reply by Authors.
Gill BC, Thomas S, Barden L, Jelovsek JE, Meyer I, Chermansky C, Komesu YM, Menefee S, Myers D, Smith A, Mazloomdoost D, Amundsen CL. Gill BC, et al. Among authors: thomas s. J Urol. 2023 Aug;210(2):340. doi: 10.1097/JU.0000000000003498.02. Epub 2023 May 22. J Urol. 2023. PMID: 37211805 No abstract available.
10,159 results
You have reached the last available page of results. Please see the User Guide for more information.